JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 11.80
+0.55 (4.89%)
At close: Nov 6, 2026
JFL Life Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 389 | 282 | 576 | 433 | 363 | - | |
Market Cap Growth | -9.23% | -51.00% | 33.04% | 19.24% | - | - |
Enterprise Value | 598 | 372 | 678 | 503 | 417 | - |
Last Close Price | 11.80 | 8.55 | 16.66 | 12.47 | 10.46 | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 4.30 | 4.41 | 13.85 | 13.11 | 12.92 | - |
PS Ratio | 0.20 | 0.22 | 0.70 | 0.92 | 0.82 | - |
PB Ratio | 0.76 | 0.62 | 1.46 | 1.22 | 1.13 | - |
P/TBV Ratio | 0.76 | 0.62 | 1.46 | 1.22 | 1.13 | - |
P/FCF Ratio | - | - | - | 18.86 | - | - |
P/OCF Ratio | - | - | - | 5.15 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.30 | 0.28 | 0.83 | 1.07 | 0.94 | - |
EV/EBITDA Ratio | 3.83 | 3.19 | 8.30 | 10.02 | 7.86 | - |
EV/EBIT Ratio | 4.14 | 3.50 | 9.40 | 10.90 | 8.55 | - |
EV/FCF Ratio | - | - | - | 21.90 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.42 | 0.47 | 0.27 | 0.16 | 0.22 | 1.40 |
Debt / EBITDA Ratio | 1.39 | 1.85 | 1.29 | 1.13 | 1.35 | 2.61 |
Debt / FCF Ratio | - | - | - | 2.48 | - | 25.16 |
Net Debt / Equity Ratio | 0.41 | 0.44 | 0.27 | 0.15 | 0.22 | 1.39 |
Net Debt / EBITDA Ratio | 1.34 | 1.74 | 1.29 | 1.05 | 1.34 | 2.58 |
Net Debt / FCF Ratio | -2.20 | -2.63 | -2.66 | 2.29 | -0.79 | 24.86 |
Asset Turnover | 1.70 | 1.48 | 1.28 | 0.89 | 0.91 | 0.89 |
Inventory Turnover | 5.34 | 4.03 | 3.40 | 2.81 | 2.53 | 2.50 |
Quick Ratio | 1.04 | 1.03 | 1.11 | 1.28 | 1.48 | 0.71 |
Current Ratio | 1.54 | 1.73 | 1.88 | 2.11 | 2.70 | 1.38 |
Return on Equity (ROE) | 19.32% | 15.00% | 11.08% | 9.73% | 12.90% | 30.77% |
Return on Assets (ROA) | 7.68% | 7.46% | 7.00% | 5.45% | 6.25% | 9.25% |
Return on Invested Capital (ROIC) | 15.57% | 13.64% | 10.76% | 10.00% | 11.09% | 16.64% |
Return on Capital Employed (ROCE) | 23.50% | 20.00% | 17.90% | 12.80% | 14.40% | 28.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 23.24% | 22.69% | 7.22% | 7.63% | 7.74% | - |
FCF Yield | -24.27% | -27.33% | -6.87% | 5.30% | -24.93% | - |
Dividend Yield | - | - | - | 0.64% | - | - |
Payout Ratio | - | - | 6.61% | - | - | - |
Buyback Yield / Dilution | 25.06% | - | -0.00% | -13.37% | -42.40% | -11.93% |
Total Shareholder Return | 25.06% | - | -0.00% | -12.74% | -42.40% | -11.93% |